EC
EcoR1 Capital’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $206M | Hold |
11,895,808
| – | – | 12.19% | 2 |
|
|
2025
Q1 | $260M | Buy |
11,895,808
+4,965
| +0% | +$109K | 15.43% | 1 |
|
|
2024
Q4 | $379M | Hold |
11,890,843
| – | – | 14.35% | 1 |
|
|
2024
Q3 | $343M | Buy |
11,890,843
+283,418
| +2% | +$8.17M | 11.74% | 1 |
|
|
2024
Q2 | $445M | Buy |
11,607,425
+250,000
| +2% | +$9.59M | 13.62% | 1 |
|
|
2024
Q1 | $668M | Buy |
11,357,425
+184,357
| +2% | +$10.8M | 16.89% | 1 |
|
|
2023
Q4 | $669M | Buy |
11,173,068
+273,209
| +3% | +$16.4M | 17.37% | 1 |
|
|
2023
Q3 | $415M | Buy |
10,899,859
+5,448,212
| +100% | +$207M | 13.99% | 2 |
|
|
2023
Q2 | $497M | Hold |
5,451,647
| – | – | 12.17% | 2 |
|
|
2023
Q1 | $360M | Buy |
5,451,647
+268,216
| +5% | +$17.7M | 11.58% | 3 |
|
|
2022
Q4 | $268M | Hold |
5,183,431
| – | – | 8.16% | 3 |
|
|
2022
Q3 | $354M | Hold |
5,183,431
| – | – | 10.45% | 2 |
|
|
2022
Q2 | $234M | Hold |
5,183,431
| – | – | 8.09% | 2 |
|
|
2022
Q1 | $263M | Buy |
5,183,431
+1,149,549
| +28% | +$58.4M | 8.24% | 2 |
|
|
2021
Q4 | $191M | Buy |
+4,033,882
| New | +$191M | 6.08% | 5 |
|
|
2018
Q2 | – | Sell |
-1,056,348
| Closed | -$23.4M | – | 30 |
|
|
2018
Q1 | $23.4M | Sell |
1,056,348
-88,210
| -8% | -$1.95M | 2.34% | 11 |
|
|
2017
Q4 | $24.8M | Buy |
+1,144,558
| New | +$24.8M | 2.8% | 10 |
|